Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The top clinical trial opportunities in therapeutic apheresis and neurology.
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
[Multiple sclerosis in Argentina. Systematic review and meta-analysis].
Temporal aspects of visual perception in demyelinative diseases.
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
New treatments for multiple sclerosis: at what long-term risk?
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
Cortical and leptomeningeal involvement in three cases of neuromyelitis optica.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review.
Chromatic visual evoked potentials in young patients with demyelinating disease.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
[Diet and multiple sclerosis].
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
[The quality of nighttime sleep in patients with multiple sclerosis].
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Pages
« first
‹ previous
…
309
310
311
312
313
314
315
316
317
…
next ›
last »